FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3155144948> ?p ?o ?g. }

• W3155144948 endingPage "166151" @default.
• W3155144948 startingPage "166151" @default.
• W3155144948 abstract "Despite recent development of next-generation androgen receptor (AR) antagonists, metastatic castration-resistant prostate cancer (CRPC) remains incurable and requires deeper understanding through studies in suitable animal models. Prostate-specific deletion of Pten and Smad4 in mice recapitulated the disease progression of human prostate adenocarcinoma, including metastasis to lymph nodes and lung. Moreover, Pten/Smad4 tumors fostered an immunosuppressive microenvironment dominated by myeloid-derived suppressor cells (MDSCs). However, the response of Pten/Smad4 tumors to androgen deprivation and anti-androgen therapies has not been described. Here, we report that the combination of surgical castration and enzalutamide treatment in Pten/Smad4 mice slowed down the tumor growth and prolonged the median survival of the mice for 8 weeks. Treatment-naïve and castration-resistant primary tumors exhibited comparable levels of immune infiltrations with the exception of reduced monocytic MDSCs in CRPC. RNA profiling of treatment-naïve and castration-resistant primary tumors revealed largely preserved transcriptome with modest expressional alterations of collagen-related and immune-related genes, among which C C chemokine receptor type 2 ( Ccr2 ) downregulation and predicted negative activation in CRPC was consistent with reduced monocytic MDSC infiltration. Importantly, significant transcriptomic reprograming was observed in lung metastatic CRPC compared with primary CRPC and enriched for immune-related and coagulation-related pathways. At the individual gene level, we validated the expression changes of some of the most upregulated ( Cd36 , Bmp5 , Bmp6 , Etv5 , Prex2 , Ptprb , Egfl6 , Itga8 and Cxcl12 ) and downregulated genes ( Cxcl9 and Adamts5 ). Together, this study uncovers the inherent activity of Pten/Smad4 tumors to progress to CRPC and highlights potentially targetable transcriptomic signatures associated with CRPC metastasis." @default.
• W3155144948 created "2021-04-26" @default.
• W3155144948 creator A5001979626 @default.
• W3155144948 creator A5003972456 @default.
• W3155144948 creator A5016770515 @default.
• W3155144948 creator A5030199923 @default.
• W3155144948 creator A5063404786 @default.
• W3155144948 creator A5089966579 @default.
• W3155144948 date "2021-07-01" @default.
• W3155144948 modified "2023-09-26" @default.
• W3155144948 title "Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model" @default.
• W3155144948 cites W1964636114 @default.
• W3155144948 cites W1975577875 @default.
• W3155144948 cites W1988305905 @default.
• W3155144948 cites W2000825526 @default.
• W3155144948 cites W2014958760 @default.
• W3155144948 cites W2027130619 @default.
• W3155144948 cites W2032268859 @default.
• W3155144948 cites W2046234516 @default.
• W3155144948 cites W2138326965 @default.
• W3155144948 cites W2144935753 @default.
• W3155144948 cites W2149570955 @default.
• W3155144948 cites W2149793889 @default.
• W3155144948 cites W2151419509 @default.
• W3155144948 cites W2165300664 @default.
• W3155144948 cites W2168695856 @default.
• W3155144948 cites W2181283187 @default.
• W3155144948 cites W2206971126 @default.
• W3155144948 cites W2431963657 @default.
• W3155144948 cites W2560396365 @default.
• W3155144948 cites W2595314544 @default.
• W3155144948 cites W2604936103 @default.
• W3155144948 cites W2606683026 @default.
• W3155144948 cites W2607041430 @default.
• W3155144948 cites W2765669897 @default.
• W3155144948 cites W2770893462 @default.
• W3155144948 cites W2791327106 @default.
• W3155144948 cites W2803285371 @default.
• W3155144948 cites W2811252608 @default.
• W3155144948 cites W2886348861 @default.
• W3155144948 cites W2889646458 @default.
• W3155144948 cites W2901202720 @default.
• W3155144948 cites W2913214687 @default.
• W3155144948 cites W2943173699 @default.
• W3155144948 cites W2966872601 @default.
• W3155144948 cites W3010598561 @default.
• W3155144948 cites W3035757680 @default.
• W3155144948 cites W3083681037 @default.
• W3155144948 doi "https://doi.org/10.1016/j.bbadis.2021.166151" @default.
• W3155144948 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33892077" @default.
• W3155144948 hasPublicationYear "2021" @default.
• W3155144948 type Work @default.
• W3155144948 sameAs 3155144948 @default.
• W3155144948 citedByCount "4" @default.
• W3155144948 countsByYear W31551449482022 @default.
• W3155144948 countsByYear W31551449482023 @default.
• W3155144948 crossrefType "journal-article" @default.
• W3155144948 hasAuthorship W3155144948A5001979626 @default.
• W3155144948 hasAuthorship W3155144948A5003972456 @default.
• W3155144948 hasAuthorship W3155144948A5016770515 @default.
• W3155144948 hasAuthorship W3155144948A5030199923 @default.
• W3155144948 hasAuthorship W3155144948A5063404786 @default.
• W3155144948 hasAuthorship W3155144948A5089966579 @default.
• W3155144948 hasBestOaLocation W31551449481 @default.
• W3155144948 hasConcept C104317684 @default.
• W3155144948 hasConcept C121608353 @default.
• W3155144948 hasConcept C126322002 @default.
• W3155144948 hasConcept C143998085 @default.
• W3155144948 hasConcept C150194340 @default.
• W3155144948 hasConcept C162317418 @default.
• W3155144948 hasConcept C2776235491 @default.
• W3155144948 hasConcept C2777911890 @default.
• W3155144948 hasConcept C2779256933 @default.
• W3155144948 hasConcept C2779279991 @default.
• W3155144948 hasConcept C2780192828 @default.
• W3155144948 hasConcept C502942594 @default.
• W3155144948 hasConcept C54355233 @default.
• W3155144948 hasConcept C61367390 @default.
• W3155144948 hasConcept C71315377 @default.
• W3155144948 hasConcept C71924100 @default.
• W3155144948 hasConcept C77255625 @default.
• W3155144948 hasConcept C86803240 @default.
• W3155144948 hasConceptScore W3155144948C104317684 @default.
• W3155144948 hasConceptScore W3155144948C121608353 @default.
• W3155144948 hasConceptScore W3155144948C126322002 @default.
• W3155144948 hasConceptScore W3155144948C143998085 @default.
• W3155144948 hasConceptScore W3155144948C150194340 @default.
• W3155144948 hasConceptScore W3155144948C162317418 @default.
• W3155144948 hasConceptScore W3155144948C2776235491 @default.
• W3155144948 hasConceptScore W3155144948C2777911890 @default.
• W3155144948 hasConceptScore W3155144948C2779256933 @default.
• W3155144948 hasConceptScore W3155144948C2779279991 @default.
• W3155144948 hasConceptScore W3155144948C2780192828 @default.
• W3155144948 hasConceptScore W3155144948C502942594 @default.
• W3155144948 hasConceptScore W3155144948C54355233 @default.
• W3155144948 hasConceptScore W3155144948C61367390 @default.
• W3155144948 hasConceptScore W3155144948C71315377 @default.
• W3155144948 hasConceptScore W3155144948C71924100 @default.

• next